Triplex-forming oligonucleotides as an anti-gene technique for cancer therapy

HIGHLIGHTS

• who: December and colleagues from the Northwestern Polytechnical University, China have published the paper: Triplex-forming oligonucleotides as an anti-gene technique for cancer therapy, in the Journal: (JOURNAL)
• what: This study provides a new approach for controlling c-myc gene silencing in time and space (Huo et_al, 2019). degradation, which may contribute to maintaining the effect of TFO on bcl-2 expression last for 72 h after transfection (Shen et_al, 2001). The experiments described in the previous section have shown that TFOs can be used as antigene agents to control the activity of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.